Mary Caffrey is the Executive Editor for The American Journal of Managed Care® (AJMC®). She joined AJMC® in 2013 and is the primary staff editor for Evidence-Based Oncology, the multistakeholder publication that reaches 22,000+ oncology providers, policy makers and formulary decision makers. She is also part of the team that oversees speaker recruitment and panel preparations for AJMC®'s premier annual oncology meeting, Patient-Centered Oncology Care®. For more than a decade, Mary has covered ASCO, ASH, ACC and other leading scientific meetings for AJMC readers.
Mary has a BA in communications and philosophy from Loyola University New Orleans. You can connect with Mary on LinkedIn.
Revised House Republican Plan Would Give Some Powers to States
The compromise to align interests of the conservative Freedom Caucus and the moderate Tuesday Group would give governors and state legislatures the final say on whether to remove essential health benefits or create a high-risk pool for those with expensive chronic conditions.
Joslin's New Test Finds Patients With Diabetes at High Risk of Kidney Failure
Standard biomarker tests miss many patients who develop kidney failure. Also, many patients who are not at high risk end up in clinical trials, adding expense when they will not help researchers prove anything.
Young Children Gain Glycemic Control in Artificial Pancreas Study
The small study found that elementary-school age children spent less time out of range while using the artificial pancreas system. The first product meeting the defintion of "artificial pancreas" will be available for adults from Medtronic this summer.
Medicare Issues Rules for CGM Coverage - No Smartphones Allowed
Dexcom's G5 Mobile is the only continuous glucose monitoring system that meets Medicare criteria for coverage. However, details of the coverage rules released this week state that people with diabetes who want coverage cannot use the system with a smartphone app.